These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1168 related items for PubMed ID: 19157420

  • 21. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden.
    Benedict RH, Weinstock-Guttman B, Fishman I, Sharma J, Tjoa CW, Bakshi R.
    Arch Neurol; 2004 Feb; 61(2):226-30. PubMed ID: 14967771
    [Abstract] [Full Text] [Related]

  • 22. Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis.
    Sanfilipo MP, Benedict RH, Weinstock-Guttman B, Bakshi R.
    Neurology; 2006 Mar 14; 66(5):685-92. PubMed ID: 16534104
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Cognitive impairment and structural brain damage in benign multiple sclerosis.
    Rovaris M, Riccitelli G, Judica E, Possa F, Caputo D, Ghezzi A, Bertolotto A, Capra R, Falautano M, Mattioli F, Martinelli V, Comi G, Filippi M.
    Neurology; 2008 Nov 04; 71(19):1521-6. PubMed ID: 18815387
    [Abstract] [Full Text] [Related]

  • 26. Voxel-based morphometry reveals extra-nigral atrophy patterns associated with dopamine refractory cognitive and motor impairment in parkinsonism.
    Camicioli R, Gee M, Bouchard TP, Fisher NJ, Hanstock CC, Emery DJ, Martin WR.
    Parkinsonism Relat Disord; 2009 Mar 04; 15(3):187-95. PubMed ID: 18573676
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Goretti B, Caniatti L, Di Monte E, Ferrazza P, Brescia Morra V, Lo Fermo S, Picconi O, Luccichenti G, COGIMUS Study Group.
    Mult Scler; 2009 Jul 04; 15(7):779-88. PubMed ID: 19542262
    [Abstract] [Full Text] [Related]

  • 29. Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis.
    Dineen RA, Vilisaar J, Hlinka J, Bradshaw CM, Morgan PS, Constantinescu CS, Auer DP.
    Brain; 2009 Jan 04; 132(Pt 1):239-49. PubMed ID: 18953055
    [Abstract] [Full Text] [Related]

  • 30. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Portaccio E, Goretti B, Zipoli V, Nacmias B, Stromillo ML, Bartolozzi ML, Siracusa G, Guidi L, Federico A, Sorbi S, De Stefano N, Amato MP.
    Mult Scler; 2009 Dec 04; 15(12):1489-94. PubMed ID: 19965518
    [Abstract] [Full Text] [Related]

  • 31. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
    Schmierer K, Parkes HG, So PW, An SF, Brandner S, Ordidge RJ, Yousry TA, Miller DH.
    Brain; 2010 Mar 04; 133(Pt 3):858-67. PubMed ID: 20123726
    [Abstract] [Full Text] [Related]

  • 32. Evidence of thalamic gray matter loss in pediatric multiple sclerosis.
    Mesaros S, Rocca MA, Absinta M, Ghezzi A, Milani N, Moiola L, Veggiotti P, Comi G, Filippi M.
    Neurology; 2008 Mar 25; 70(13 Pt 2):1107-12. PubMed ID: 18272867
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.
    Ramasamy DP, Benedict RH, Cox JL, Fritz D, Abdelrahman N, Hussein S, Minagar A, Dwyer MG, Zivadinov R.
    J Neurol Sci; 2009 Jul 15; 282(1-2):47-54. PubMed ID: 19201003
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Focal thinning of the cerebral cortex in multiple sclerosis.
    Sailer M, Fischl B, Salat D, Tempelmann C, Schönfeld MA, Busa E, Bodammer N, Heinze HJ, Dale A.
    Brain; 2003 Aug 15; 126(Pt 8):1734-44. PubMed ID: 12805100
    [Abstract] [Full Text] [Related]

  • 40. Significance of T2 lesions in multiple sclerosis: A 13-year longitudinal study.
    Rudick RA, Lee JC, Simon J, Fisher E.
    Ann Neurol; 2006 Aug 15; 60(2):236-42. PubMed ID: 16786526
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 59.